Skip to main content
. 2021 Mar 8;33(2):138–146. doi: 10.5021/ad.2021.33.2.138

Fig. 2. AHR, CYP1A1, and LC3 immunohistochemical expression in psoriasis lesional skin and normal skin. (A) Normal control skin sample with mild (+1) basal pattern CYP1A1 expression (×200). (B) Normal control skin sample with negative. (0) AHR expression (×200). (C) Normal control skin sample with negative. (0) LC3 expression (×200). (D) Psoriasis specimen (lesional skin) showing a moderate (+2) basal and suprabasal pattern of CYP1A1 expression (×200). (E) Psoriasis specimen (lesional skin) showing a strong (+3) basal and suprabasal pattern of AHR expression (×200). (F) Psoriasis specimen (lesional skin) showing a mild (+1) basal and suprabasal pattern of LC3 expression (×200). Bar=75 µm. AHR: aryl hydrocarbon receptor, LC3: microtubule-associated protein light chain 3.

Fig. 2